Kidney Diseases Metabolomics Service

Metabolomics allows qualitative and quantitative analysis of changes in various metabolites or changes in these metabolites over time in biological organisms including cells, organs and systems under the influence of internal and external factors.

The development of kidney disease is influenced by a variety of factors inside and outside the organism, and is closely related to the abnormalities of the organism's metabolism, which is manifested by changes in various metabolites. As the end products of various pathophysiological processes in biological organisms, metabolites provide many useful clues for the in-depth understanding of various physiopathological phenomena and disease pathogenesis in the organism. Due to the pathophysiological characteristics of kidney diseases, their metabolic changes can be reflected by quantitative studies of blood and urine. The metabolic changes in renal diseases can be reflected by quantitative studies of blood and urine.

Creative Proteomics provides metabolomics solutions to help discover new small molecule biomarkers for kidney diseases, elucidate the mechanisms of disease development, and provide theoretical basis for diagnosis and differential diagnosis, dynamic observation of disease progression and prognostic assessment.

Metabolomics Analysis Process for Kidney Diseases

Technology Platform for Metabolomics Analysis

Multiple analytical platforms, including GC-MS, LC-MS, UPLC-MS. Thousands of metabolites can be screened from a single biological sample, providing a comprehensive approach for probing disease mechanisms.

Creative Proteomics is a well-established partner in biopharmaceutical research and has extensive experience in metabolomics analysis. We provide solutions for kidney diseases in the direction of metabolomics analysis, accelerating the exploration of new horizons in science. If you want to know more, please contact us. Looking forward to cooperating with you.